{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:23:03Z","timestamp":1787736183898,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.blre.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T19:45:10Z","timestamp":1548531910000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Radiosynovectomy in haemophilia"],"prefix":"10.1016","volume":"35","author":[{"given":"E. Carlos","family":"Rodriguez-Merchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2019.01.002_bb0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.blre.2016.04.008","article-title":"Musculo-skeletal manifestations of haemophilia","volume":"30","author":"Rodriguez-Merchan","year":"2016","journal-title":"Blood Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2019.01.002_bb0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2516.9.s1.1.x","article-title":"When to start and when to stop primary prophylaxis in patients with severe haemophilia","volume":"9","author":"Astermark","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/j.blre.2019.01.002_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2516.2012.02839.x","article-title":"Models of prophylaxis","volume":"18","author":"Berntorp","year":"2012","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2019.01.002_bb0025","first-page":"S23","article-title":"Hemophilia and prophylaxis","volume":"60","author":"Ljung","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2019.01.002_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0268-960X(03)00038-9","article-title":"Prophylactic factor replacement in hemophilia","volume":"18","author":"Carcao","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2019.01.002_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.blre.2009.08.001","article-title":"Prophylactic therapy in haemophilia","volume":"23","author":"Ljung","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2019.01.002_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.blre.2013.02.003","article-title":"Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies","volume":"27","author":"Teitel","year":"2013","journal-title":"Blood Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2019.01.002_bb0045","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0268-960X(08)70001-8","article-title":"From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitors","volume":"22","author":"Gomperts","year":"2008","journal-title":"Blood Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2019.01.002_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2516.2001.00109.x","article-title":"32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis","volume":"7","author":"Silva","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00003086-200111000-00054","article-title":"Phosphate-32 colloid radiosynovectomy in hemophilia: outcome of 125 procedures","author":"Siegel","year":"2001","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2019.01.002_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2516.2001.00108.x","article-title":"Synoviorthesis with radioactive Yttrium in haemophilia: Israel experience","volume":"7","author":"Heim","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2516.2006.01424.x","article-title":"(32)P colloid radiosynovectomy in treatment of chronic haemophilic synovitis: Iran experience","volume":"13","author":"Mortazavi","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2516.2008.01908.x","article-title":"Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy","volume":"15","author":"Calegaro","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2516.2009.02192.x","article-title":"Radioisotope synoviorthesis with Holmium-166-chitosan complex in haemophilic arthropathy","volume":"16","author":"Cho","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0609.2011.01583.x","article-title":"Radiosynovectomy in patients with chronic haemophilic synovitis: when is more than one injection necessary?","volume":"86","author":"De la Corte-Rodriguez","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2019.01.002_bb0085","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1538-7836.2011.04246.x","article-title":"Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters","volume":"9","author":"De la Corte-Rodriguez","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2019.01.002_bb0090","doi-asserted-by":"crossref","first-page":"e990","DOI":"10.1111\/j.1365-2516.2011.02546.x","article-title":"What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia?","volume":"17","author":"De la Corte-Rodriguez","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0095","first-page":"254","article-title":"Consecutive radiosynovectomy procedures at 6-monthly intervals behave independently in haemophilic synovitis","volume":"11","author":"De la Corte-Rodriguez","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2019.01.002_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.thromres.2014.01.030","article-title":"Is radiosynovectomy (RS) effective for joints damaged by haemophilia with articular degeneration in simple radiography (ADSR)?","volume":"133","author":"Rodriguez-Merchan","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2019.01.002_bb0105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.thromres.2014.08.023","article-title":"Radiosynovectomy in haemophilia: long-term results of 500 procedures performed in a 38-year period","volume":"134","author":"Rodriguez-Merchan","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2019.01.002_bb0110","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/hae.12252","article-title":"Survival analysis of Y-90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10-year retrospective review","volume":"20","author":"Turkmen","year":"2014","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2019.01.002_bb0115","first-page":"S62","article-title":"Radiosynoviorthesis in children with haemophilia","volume":"29","author":"Pasta","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.blre.2019.01.002_bb0120","first-page":"122","article-title":"Ultrasound in the diagnosis of the early stages of hemophilic arthropathy of the knee","volume":"58","author":"Merchan","year":"1992","journal-title":"Acta Orthop Belg"},{"key":"10.1016\/j.blre.2019.01.002_bb0125","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1160\/TH12-11-0874","article-title":"Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)","volume":"109","author":"Martinoli","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2019.01.002_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/17474086.2018.1435269","article-title":"The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia","volume":"11","author":"De la Corte-Rodriguez","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2019.01.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13524","article-title":"Diagnostic accuracy of point-of-care ultrasound for evaluation of early blood-induced joint changes: comparison with MRI","author":"Foppen","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0140","article-title":"Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status","author":"Di Minno","year":"2018","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2019.01.002_bb0145","doi-asserted-by":"crossref","first-page":"W336","DOI":"10.2214\/AJR.14.12501","article-title":"Diagnostic accuracy of ultrasound for assessment of hemophilic arthropathy: MRI correlation","volume":"204","author":"Doria","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.blre.2019.01.002_bb0150","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1111\/hae.12268","article-title":"Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia","volume":"20","author":"Sierra Aisa","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2516.2003.00771.x","article-title":"Long-term FEIBA prophylaxis does not prevent progression of existing joint disease","volume":"9","author":"Hilgartner","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2516.2005.01096.x","article-title":"Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors","volume":"11","author":"Young","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2516.2007.01442.x","article-title":"Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors","volume":"13","author":"Leissinger","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2516.2007.01632.x","article-title":"Some recent developments regarding arthropathy and inhibitors in haemophilia","volume":"14","author":"Rodriguez-Merchan","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2019.01.002_bb0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2516.2008.01736.x","article-title":"Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors","volume":"14","author":"Fischer","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MBC.0b013e328309907a","article-title":"\u201cPrimary prophylaxis\u201d with rFVIIa in a patient with severe haemophilia A and inhibitor","volume":"19","author":"Jimenez-Yuste","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2019.01.002_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2008.01881.x","article-title":"Prevention of haemophilic arthropathy in haemophilic children with inhibitors","volume":"14","author":"Rodriguez-Merchan","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2019.01.002_bb0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2516.2008.01887.x","article-title":"Experiences in the prevention of arthropathy in haemophila patients with inhibitors","volume":"14","author":"Jimenez-Yuste","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2516.2008.01915.x","article-title":"Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations","volume":"15","author":"Jimenez-Yuste","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2516.2009.01980.x","article-title":"The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series","volume":"15","author":"Valentino","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0205","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0029-1245114","article-title":"Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII","volume":"35","author":"Franchini","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2019.01.002_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2516.2009.02104.x","article-title":"FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations","volume":"16","author":"Perry","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2516.2009.02116.x","article-title":"Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: a prospective clinical case series","volume":"16","author":"Ettingshausen","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2516.2009.02126.x","article-title":"Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors","volume":"16","author":"Valentino","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0225","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1111\/j.1365-2516.2011.02494.x","article-title":"When should prophylaxis therapy in inhibitor patients be considered?","volume":"17","author":"Young","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2019.01.002_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2011.02615.x","article-title":"Joint protection in haemophilia","volume":"17","author":"Rodriguez-Merchan","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/hae.12178","article-title":"Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study","volume":"19","author":"Gringeri","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0240","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/hae.12390","article-title":"Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life inhaemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study","volume":"20","author":"Stasyshyn","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0245","first-page":"41","article-title":"Synoviorthesis in patients with hemophilia and inhibitors","volume":"127","author":"Rivard","year":"1982","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.blre.2019.01.002_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08880019209018332","article-title":"Synoviorthesis in young patients with hemophilia and inhibitory antibodies","volume":"9","author":"L\u00f6fqvist","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2019.01.002_bb0255","first-page":"37","article-title":"Radioactive synoviorthesis in patients with hemophilia with factor inhibitor","volume":"343","author":"L\u00f6fqvist","year":"1997","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2019.01.002_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2516.2007.01540.x","article-title":"Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors","volume":"13","author":"Rodriguez-Merchan","year":"2007","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2019.01.002_bb0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2516.2008.01890.x","article-title":"Synoviorthesis in haemophilia patients with inhibitors","volume":"14","author":"Pasta","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5114\/reum.2016.61210","article-title":"Radionuclide synovectomy - essentials for rheumatologists","volume":"54","author":"Chojnowski","year":"2016","journal-title":"Reumatologia"},{"key":"10.1016\/j.blre.2019.01.002_bb0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2016.02.007","article-title":"Radiosynovectomy in haemophilic synovitis of elbows and ankles: is the effectiveness of yttrium-90 and rhenium-186 different?","volume":"140","author":"Rodriguez-Merchan","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2019.01.002_bb0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0019-5413.173507","article-title":"Effects of intraarticular (32)P colloid in the treatment of hemophilic synovitis of the knee: a short term clinical study","volume":"50","author":"Zhang","year":"2016","journal-title":"Indian J Orthop"},{"key":"10.1016\/j.blre.2019.01.002_bb0285","first-page":"39","article-title":"Therapeutic response of radiosynovectomy with p-32 colloid in 326 patients with hemophilic arthropathy. [Article in Chinese; Abstract available in Chinese from the publisher]","volume":"38","author":"Wang","year":"2017","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.blre.2019.01.002_bb0290","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2003-05-1457","article-title":"Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors","volume":"103","author":"Soucie","year":"2004","journal-title":"Blood"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2019.01.002_bb0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2516.2006.01369.x","article-title":"Prophylaxis in haemophilia patients with inhibitors","volume":"12","author":"Leissinger","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2019.01.002_bb0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2516.2008.01885.x","article-title":"Articular status of haemophilia patients with inhibitors","volume":"14","author":"Morfini","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0305","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2516.2009.02032.x","article-title":"Health-related quality of life and productivity impact in haemophilia patients with inhibitors","volume":"15","author":"Brown","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0310","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1111\/hae.12393","article-title":"Efficacy of celecoxib in the treatment of joint pain caused by advanced haemophilic arthropathy in adult patients with haemophilia A","volume":"20","author":"Rodriguez-Merchan","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2019.01.002_bb0315","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0037-1613015","article-title":"Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol","volume":"87","author":"Dunn","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2019.01.002_bb0320","first-page":"393","article-title":"The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid","volume":"22","author":"Turkmen","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.blre.2019.01.002_bb0325","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2516.2012.02802.x","article-title":"A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis","volume":"18","author":"Infante-Rivard","year":"2012","journal-title":"Haemophilia"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X18300912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X18300912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:22:11Z","timestamp":1759436531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X18300912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":65,"alternative-id":["S0268960X18300912"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2019.01.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosynovectomy in haemophilia","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}